Search research articles
Contact Us
Filters
Showing results (241-250 of 345) with videos related to
Page
of 35
Sort By:
Journal of Neuropathology and Experimental Neurology
|
March 6, 2024
Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?
Kliment Donev, Vanitha Sundararajan, Derek Johnson, et al.
Research Square
|
June 5, 2026
SYNTHESIS-Breast: A prospective early-phase trial of a genetic-interaction- focused computational algorithm in advanced metastatic breast cancer
Aanika B Warner, Britanny B Solarz, Miroslava Belyov, et al.
Biorxiv : the Preprint Server for Biology
|
November 26, 2025
Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomas
Maxwell T Laws, Dhruval Bhatt, Debjani Mandal, et al.
Neuro-Oncology
|
April 14, 2026
CNS tumor type prevalence according to age group: an analysis of 21,000 cases confirmed by methylation profiling, with a focus on adolescents and young adults
Adriana Fonseca, Leeor Yefet, Omkar Singh, et al.
Neuro-Oncology
|
August 17, 2022
Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas
Mark W Youngblood, Anh N Tran, Wenxia Wang, et al.
Archives of Pathology & Laboratory Medicine
|
February 17, 2022
Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas
Daniel J Brat, Kenneth Aldape, Julia A Bridge, et al.
JAMA Oncology
|
December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review
Craig Horbinski, David A Solomon, Rimas V Lukas, et al.
American Journal of Clinical Pathology
|
October 22, 2015
Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing
Sinchita Roy-Chowdhuri, Debora de Melo Gagliato, Mark J Routbort, et al.
Journal of Neuropathology and Experimental Neurology
|
June 12, 2025
FGFR1 fusions in genomically and epigenetically bona fide glioblastoma, IDH-wildtype
Riley H Lochner, Suzanne Z Powell, Kar-Ming Fung, et al.
Neuro-Oncology Advances
|
February 29, 2024
Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findings
Nicole Briceno, Elizabeth Vera, Edina Komlodi-Pasztor, et al.
Page
of 35
Search research articles
Search
Showing results (241-250 of 345) with videos related to
Sort By:
Page
of 35
Journal of Neuropathology and Experimental Neurology
|
March 6, 2024
Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?
Kliment Donev, Vanitha Sundararajan, Derek Johnson, et al.
Research Square
|
June 5, 2026
SYNTHESIS-Breast: A prospective early-phase trial of a genetic-interaction- focused computational algorithm in advanced metastatic breast cancer
Aanika B Warner, Britanny B Solarz, Miroslava Belyov, et al.
Biorxiv : the Preprint Server for Biology
|
November 26, 2025
Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomas
Maxwell T Laws, Dhruval Bhatt, Debjani Mandal, et al.
Neuro-Oncology
|
April 14, 2026
CNS tumor type prevalence according to age group: an analysis of 21,000 cases confirmed by methylation profiling, with a focus on adolescents and young adults
Adriana Fonseca, Leeor Yefet, Omkar Singh, et al.
Neuro-Oncology
|
August 17, 2022
Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas
Mark W Youngblood, Anh N Tran, Wenxia Wang, et al.
Archives of Pathology & Laboratory Medicine
|
February 17, 2022
Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas
Daniel J Brat, Kenneth Aldape, Julia A Bridge, et al.
JAMA Oncology
|
December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review
Craig Horbinski, David A Solomon, Rimas V Lukas, et al.
American Journal of Clinical Pathology
|
October 22, 2015
Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing
Sinchita Roy-Chowdhuri, Debora de Melo Gagliato, Mark J Routbort, et al.
Journal of Neuropathology and Experimental Neurology
|
June 12, 2025
FGFR1 fusions in genomically and epigenetically bona fide glioblastoma, IDH-wildtype
Riley H Lochner, Suzanne Z Powell, Kar-Ming Fung, et al.
Neuro-Oncology Advances
|
February 29, 2024
Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findings
Nicole Briceno, Elizabeth Vera, Edina Komlodi-Pasztor, et al.
Page
of 35